MEKAR (MEK Inhibitor Associated Retinopathy)

  • Typically bilateral, can be unilateral (rare)
  • ~50% of patients may be symptomatic with vision loss no more than 2 Snellen lines of acuity from baseline (and returns to within 1 line of baseline after fluid resolution)
  • OCT characteristics: fluid accumulation between RPE and IZ in various configurations (see next slide)
  • MEK Inhibitor does not need to be stopped for fluid to resolve